Elo Life Systems

Investment area

Bioindustrial Investments

Growth Investments


North America

Date of investment

April 2022

Elo is dedicated to improving human health and wellness through food by integrating technologies and enabling efficient food production systems.

Visit site


Stephen van Helden


Departments: Growth Investments, Novo Holdings Equity US Inc., Bioindustrial Investments

Stephen joined Novo Holdings in 2022.

Prior to joining Novo Holdings, Stephen spent over 5 years developing new products, partnerships and businesses at The Production Board as an EIR, and Zymergen where he led many Industrial efforts including across Agriculture, Food and Packaging. He previously worked with McKinsey and Company as an Associate Partner across a number of sectors and geographies.

Stephen holds an MBA from Stanford University and a BSc in Electrical Engineering from the University of Cape Town.